Last updated 2026-07-26
- Raised $3.5M Seed round led by FutuRx, Jan 2019
Total raised
$3.5M
Last: Undisclosed Round 2019-02
Stage
Seed
Founded
2020
Headcount
4
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences
About
Epeius Pharma is a cell and gene therapy company focused on developing biological vehicles for the delivery of therapeutic proteins into the central nervous system (CNS). Their platform aims to provide an effective and scalable strategy for disease medication in neurodevelopmental and neurological pathologies that could benefit from direct neuron protein replacement treatments. The company's first target indication is Rett syndrome. Epeius Pharma was founded based on joint research efforts from Tel Aviv University and the University of Glasgow, and was licensed from Ramot, the technology transfer company of Tel Aviv University and Glasgow University.
Funding history · 1 round · $3.5M total
2019-01
Seed
$3.5M
★ FutuRx★ RMGP Biopharma Investment Fund
Headcount over time
From 3 (2022-01) to 3 (2026-03) · +0 (+0%) · 11 points · source: Finder history + radar grounding
Q&A
- What is Epeius Pharma's primary focus?
- Epeius Pharma is a cell and gene therapy company developing biological vehicles for the delivery of therapeutic proteins into the central nervous system (CNS).
- When was Epeius Pharma founded?
- Epeius Pharma was founded in January 2020.
- What is Epeius Pharma's first target indication?
- Epeius Pharma's first target indication is Rett syndrome.
- From which institutions did Epeius Pharma license its technology?
- Epeius Pharma's technology was licensed from Ramot, the technology transfer company of Tel Aviv University and Glasgow University, based on joint research efforts from both universities.
- How many employees does Epeius Pharma currently have?
- Epeius Pharma has 1-10 employees.
- What is the total amount of funding Epeius Pharma has raised to date?
- Epeius Pharma has raised a total of $3,500,000 USD.
- Who are the co-founders of Epeius Pharma?
- The co-founders of Epeius Pharma are Prof. Oded Rechavi, Shahar Bracha, and Dr. Lilach Sheiner.
Team · 3
Prof. Oded Rechavi
Founder · Co-Founder
Shahar Bracha
Founder · Co-Founder
Dr. Lilach Sheiner
Founder · Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
BiologicalsGenesCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Tags
therapeuticsneurologycns-disorderscell-therapyproteinsdrug-deliverypharmaceuticals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | futurx.co.il/cgi-sys/suspendedpage.cgi |
|---|---|
| linkedin.com/company/77039352 |
Identifiers & details
| Legal name | Epeius Pharma Ltd. |
|---|---|
| Founded | 2020-1 |
| Employees (exact) | 4 |
Radar intelligence
Web history (Wayback)
| Domain | futurx.co.il |
|---|
Certificate / subdomain footprint
| Subdomains | 10 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515982965 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2019-02-18 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2023 |
| Active charges / liens | 0 |
| Registry events | 1 — violation (1) |
| Registered address | רמון אילן 2 נס ציונה |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-25 | עדכון הפרה |